Heska Corp
NASDAQ:HSKA
Relative Value
There is not enough data to reliably calculate the relative value of HSKA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
HSKA Competitors Multiples
Heska Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Heska Corp
NASDAQ:HSKA
|
1.3B USD | 5.1 | -65.4 | -276.9 | -66.5 | ||
US |
Abbott Laboratories
NYSE:ABT
|
184.3B USD | 4.6 | 32.7 | 19.3 | 28.7 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
131.8B USD | 18 | 66.3 | 54.4 | 68.2 | ||
US |
Stryker Corp
NYSE:SYK
|
124.8B USD | 6 | 37.1 | 24.1 | 29.7 | ||
IE |
Medtronic PLC
NYSE:MDT
|
107.6B USD | 3.3 | 25.6 | 13.6 | 19.3 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
105.8B USD | 7.2 | 59.9 | 30.6 | 45.1 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.5B USD | 3.5 | 55.4 | 18.6 | 39.2 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 2.7 | 38.3 | 18.4 | 31 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
50.7B USD | 8.3 | 35.9 | 26.1 | 28.2 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
49.9B USD | 13.1 | 78 | 58.3 | 75.9 |